0 XP   0   0   0

Anteo Diagnostics Ltd
Buy, Hold or Sell?

Let's analyse Anteo Diagnostics Ltd together

PenkeI guess you are interested in Anteo Diagnostics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Anteo Diagnostics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Anteo Diagnostics Ltd

I send you an email if I find something interesting about Anteo Diagnostics Ltd.

Quick analysis of Anteo Diagnostics Ltd (30 sec.)










1. Valuation of Anteo Diagnostics Ltd (5 min.)




Current price per share

A$0.05

2. Growth of Anteo Diagnostics Ltd (5 min.)




Is Anteo Diagnostics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$13.2m$22.6m-$9.3m-70.9%

How much money is Anteo Diagnostics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$11.4m-$4.5m-$6.9m?
Net Profit Margin-1,408.9%-474.3%--

How much money comes from the company's main activities?

3. Financial Health of Anteo Diagnostics Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#804 / 1215

Most Revenue
#547 / 1215

Most Profit
#698 / 1215

Most Efficient
#985 / 1215


Fundamentals of Anteo Diagnostics Ltd

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Anteo Diagnostics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Anteo Diagnostics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -1,408.9% means that $-14.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -1,408.9%. The company is making a huge loss. -2
  • The TTM is -1,408.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,408.9%TTM-1,408.9%0.0%
TTM-1,408.9%YOY-474.3%-934.6%
TTM-1,408.9%5Y-1,195.1%-213.8%
5Y-1,195.1%10Y-1,072.6%-122.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,408.9%-193.4%-1,215.5%
TTM-1,408.9%-273.6%-1,135.3%
YOY-474.3%-315.2%-159.1%
5Y-1,195.1%-539.0%-656.1%
10Y-1,072.6%-664.9%-407.7%
1.1.2. Return on Assets

Shows how efficient Anteo Diagnostics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • -70.2% Return on Assets means that Anteo Diagnostics Ltd generated $-0.70 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anteo Diagnostics Ltd:

  • The MRQ is -70.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -70.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-70.2%TTM-70.2%0.0%
TTM-70.2%YOY-18.0%-52.2%
TTM-70.2%5Y-55.2%-15.0%
5Y-55.2%10Y-48.0%-7.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-70.2%-12.3%-57.9%
TTM-70.2%-12.4%-57.8%
YOY-18.0%-10.9%-7.1%
5Y-55.2%-15.3%-39.9%
10Y-48.0%-17.6%-30.4%
1.1.3. Return on Equity

Shows how efficient Anteo Diagnostics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • -86.8% Return on Equity means Anteo Diagnostics Ltd generated $-0.87 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anteo Diagnostics Ltd:

  • The MRQ is -86.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -86.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-86.8%TTM-86.8%0.0%
TTM-86.8%YOY-20.2%-66.6%
TTM-86.8%5Y-64.4%-22.4%
5Y-64.4%10Y-71.0%+6.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-86.8%-15.2%-71.6%
TTM-86.8%-15.5%-71.3%
YOY-20.2%-13.1%-7.1%
5Y-64.4%-20.4%-44.0%
10Y-71.0%-20.9%-50.1%

1.2. Operating Efficiency of Anteo Diagnostics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Anteo Diagnostics Ltd is operating .

  • Measures how much profit Anteo Diagnostics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -1,753.0% means the company generated $-17.53  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anteo Diagnostics Ltd:

  • The MRQ is -1,753.0%. The company is operating very inefficient. -2
  • The TTM is -1,753.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,753.0%TTM-1,753.0%0.0%
TTM-1,753.0%YOY-909.9%-843.0%
TTM-1,753.0%5Y-1,576.7%-176.2%
5Y-1,576.7%10Y-1,108.4%-468.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,753.0%-316.7%-1,436.3%
TTM-1,753.0%-267.4%-1,485.6%
YOY-909.9%-333.8%-576.1%
5Y-1,576.7%-517.0%-1,059.7%
10Y-1,108.4%-624.7%-483.7%
1.2.2. Operating Ratio

Measures how efficient Anteo Diagnostics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 18.53 means that the operating costs are $18.53 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 18.530. The company is inefficient in keeping operating costs low. -1
  • The TTM is 18.530. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ18.530TTM18.5300.000
TTM18.530YOY10.099+8.430
TTM18.5305Y17.090+1.440
5Y17.09010Y14.258+2.831
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.5302.989+15.541
TTM18.5303.644+14.886
YOY10.0994.537+5.562
5Y17.0906.411+10.679
10Y14.2588.312+5.946

1.3. Liquidity of Anteo Diagnostics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.70 means the company has $6.70 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 6.700. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.700. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.700TTM6.7000.000
TTM6.700YOY20.091-13.391
TTM6.7005Y10.869-4.169
5Y10.86910Y8.682+2.187
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7004.559+2.141
TTM6.7004.993+1.707
YOY20.0916.149+13.942
5Y10.8696.306+4.563
10Y8.6826.588+2.094
1.3.2. Quick Ratio

Measures if Anteo Diagnostics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 6.54 means the company can pay off $6.54 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 6.543. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.543. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.543TTM6.5430.000
TTM6.543YOY19.949-13.405
TTM6.5435Y10.689-4.146
5Y10.68910Y8.436+2.253
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5433.874+2.669
TTM6.5434.499+2.044
YOY19.9495.772+14.177
5Y10.6895.816+4.873
10Y8.4366.032+2.404

1.4. Solvency of Anteo Diagnostics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Anteo Diagnostics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anteo Diagnostics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.19 means that Anteo Diagnostics Ltd assets are financed with 19.1% credit (debt) and the remaining percentage (100% - 19.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.191. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.191. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.191TTM0.1910.000
TTM0.191YOY0.108+0.082
TTM0.1915Y0.139+0.052
5Y0.13910Y0.262-0.123
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1910.311-0.120
TTM0.1910.298-0.107
YOY0.1080.269-0.161
5Y0.1390.377-0.238
10Y0.2620.409-0.147
1.4.2. Debt to Equity Ratio

Measures if Anteo Diagnostics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 23.5% means that company has $0.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is 0.235. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.235. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.2350.000
TTM0.235YOY0.121+0.114
TTM0.2355Y0.163+0.072
5Y0.16310Y0.944-0.780
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2350.363-0.128
TTM0.2350.362-0.127
YOY0.1210.277-0.156
5Y0.1630.425-0.262
10Y0.9440.463+0.481

2. Market Valuation of Anteo Diagnostics Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Anteo Diagnostics Ltd generates.

  • Above 15 is considered overpriced but always compare Anteo Diagnostics Ltd to the Biotechnology industry mean.
  • A PE ratio of -7.68 means the investor is paying $-7.68 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is -5.438. Company is losing money. -2
  • The MRQ is -7.683. Company is losing money. -2
  • The TTM is -7.683. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-5.438MRQ-7.683+2.246
MRQ-7.683TTM-7.6830.000
TTM-7.683YOY-51.972+44.288
TTM-7.6835Y-15.503+7.820
5Y-15.50310Y-22.754+7.250
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.438-6.478+1.040
MRQ-7.683-7.165-0.518
TTM-7.683-8.420+0.737
YOY-51.972-19.867-32.105
5Y-15.503-18.328+2.825
10Y-22.754-18.055-4.699
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Anteo Diagnostics Ltd.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Anteo Diagnostics Ltd:

  • The MRQ is -27.857. Very Bad. -2
  • The TTM is -27.857. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-27.857TTM-27.8570.000
TTM-27.857YOY-4,328.293+4,300.436
TTM-27.8575Y-874.254+846.396
5Y-874.25410Y-476.262-397.991
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.857-4.292-23.565
TTM-27.857-6.108-21.749
YOY-4,328.293-13.925-4,314.368
5Y-874.254-12.525-861.729
10Y-476.262-11.713-464.549

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Anteo Diagnostics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.66 means the investor is paying $6.66 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anteo Diagnostics Ltd:

  • The EOD is 4.716. Neutral. Compare to industry.
  • The MRQ is 6.665. Seems overpriced? -1
  • The TTM is 6.665. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD4.716MRQ6.665-1.948
MRQ6.665TTM6.6650.000
TTM6.665YOY15.300-8.635
TTM6.6655Y7.618-0.953
5Y7.61810Y11.807-4.189
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.7161.890+2.826
MRQ6.6652.024+4.641
TTM6.6652.335+4.330
YOY15.3003.965+11.335
5Y7.6183.738+3.880
10Y11.8074.002+7.805
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anteo Diagnostics Ltd.


4. Summary

4.1. Key Performance Indicators

The key performance indicators of Anteo Diagnostics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.007-0.0070%0.014-149%0.001-934%0.001-1255%
Book Value Growth--0.5850.5850%6.579-91%1.909-69%1.655-65%
Book Value Per Share--0.0100.0100%0.017-41%0.007+38%0.006+52%
Book Value Per Share Growth--0.5850.5850%6.579-91%1.909-69%1.655-65%
Current Ratio--6.7006.7000%20.091-67%10.869-38%8.682-23%
Debt To Asset Ratio--0.1910.1910%0.108+76%0.139+37%0.262-27%
Debt To Equity Ratio--0.2350.2350%0.121+94%0.163+44%0.944-75%
Dividend Per Share----0%-0%-0%-0%
Eps---0.008-0.0080%-0.005-42%-0.004-50%-0.004-50%
Eps Growth--0.2760.2760%0.012+2197%0.817-66%0.713-61%
Free Cash Flow Per Share---0.002-0.0020%0.000-93%-0.001-46%-0.002-17%
Free Cash Flow Per Share Growth---12.633-12.6330%1.212-1142%-2.522-80%-0.869-93%
Free Cash Flow To Equity Per Share---0.002-0.0020%0.018-112%0.001-423%0.001-368%
Free Cash Flow To Equity Per Share Growth---0.116-0.1160%15.779-101%1.059-111%1.516-108%
Gross Profit Margin--1.1851.1850%1.314-10%1.152+3%1.276-7%
Intrinsic Value_10Y_max---0.004--------
Intrinsic Value_10Y_min---0.058--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max---0.002--------
Intrinsic Value_3Y_min---0.012--------
Intrinsic Value_5Y_max---0.003--------
Intrinsic Value_5Y_min---0.023--------
Net Profit Margin---14.089-14.0890%-4.743-66%-11.951-15%-10.726-24%
Operating Margin---17.530-17.5300%-9.099-48%-15.767-10%-11.084-37%
Operating Ratio--18.53018.5300%10.099+83%17.090+8%14.258+30%
Pb Ratio4.716-41%6.6656.6650%15.300-56%7.618-13%11.807-44%
Pe Ratio-5.438+29%-7.683-7.6830%-51.972+576%-15.503+102%-22.754+196%
Peg Ratio---27.857-27.8570%-4328.293+15437%-874.254+3038%-476.262+1610%
Price Per Share0.046-41%0.0650.0650%0.255-75%0.073-11%0.072-10%
Price To Total Gains Ratio-6.653+29%-9.401-9.4010%18.042-152%9.468-199%1.415-765%
Profit Growth---0.517-0.5170%-0.461-11%0.657-179%0.631-182%
Quick Ratio--6.5436.5430%19.949-67%10.689-39%8.436-22%
Return On Assets---0.702-0.7020%-0.180-74%-0.552-21%-0.480-32%
Return On Equity---0.868-0.8680%-0.202-77%-0.644-26%-0.710-18%
Revenue Growth--0.8470.8470%3.000-72%1.407-40%3.721-77%
Total Gains Per Share---0.007-0.0070%0.014-149%0.001-934%0.001-1255%
Total Gains Per Share Growth---0.489-0.4890%19.453-103%3.635-113%2.908-117%
Usd Book Value--13233503.90813233503.9080%22614745.321-41%9621733.982+38%8691743.471+52%
Usd Book Value Change Per Share---0.005-0.0050%0.009-149%0.001-934%0.000-1255%
Usd Book Value Per Share--0.0060.0060%0.011-41%0.005+38%0.004+52%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.006-0.0060%-0.003-42%-0.003-50%-0.003-50%
Usd Free Cash Flow---3339605.113-3339605.1130%-228217.489-93%-1801736.859-46%-2783765.811-17%
Usd Free Cash Flow Per Share---0.002-0.0020%0.000-93%-0.001-46%-0.001-17%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%0.012-112%0.000-423%0.001-368%
Usd Price Per Share0.030-41%0.0430.0430%0.169-75%0.049-11%0.048-10%
Usd Profit---11481614.348-11481614.3480%-4562022.303-60%-4994457.015-57%-5248176.939-54%
Usd Revenue--814963.002814963.0020%961907.512-15%502342.819+62%1767800.289-54%
Usd Total Gains Per Share---0.005-0.0050%0.009-149%0.001-934%0.000-1255%
 EOD+3 -2MRQTTM+0 -0YOY+3 -375Y+7 -3310Y+7 -33

4.2. Fundamental Score

Let's check the fundamental score of Anteo Diagnostics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.438
Price to Book Ratio (EOD)Between0-14.716
Net Profit Margin (MRQ)Greater than0-14.089
Operating Margin (MRQ)Greater than0-17.530
Quick Ratio (MRQ)Greater than16.543
Current Ratio (MRQ)Greater than16.700
Debt to Asset Ratio (MRQ)Less than10.191
Debt to Equity Ratio (MRQ)Less than10.235
Return on Equity (MRQ)Greater than0.15-0.868
Return on Assets (MRQ)Greater than0.05-0.702
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Anteo Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.050
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets15,264
Total Liabilities2,909
Total Stockholder Equity12,355
 As reported
Total Liabilities 2,909
Total Stockholder Equity+ 12,355
Total Assets = 15,264

Assets

Total Assets15,264
Total Current Assets10,826
Long-term Assets10,826
Total Current Assets
Cash And Cash Equivalents 10,103
Net Receivables 469
Other Current Assets 254
Total Current Assets  (as reported)10,826
Total Current Assets  (calculated)10,826
+/-0
Long-term Assets
Property Plant Equipment 4,015
Other Assets 423
Long-term Assets  (as reported)4,438
Long-term Assets  (calculated)4,438
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,616
Long-term Liabilities1,293
Total Stockholder Equity12,355
Total Current Liabilities
Short-term Debt 258
Accounts payable 704
Other Current Liabilities 655
Total Current Liabilities  (as reported)1,616
Total Current Liabilities  (calculated)1,616
+/-0
Long-term Liabilities
Long term Debt Total 776
Other Liabilities 517
Long-term Liabilities  (as reported)1,293
Long-term Liabilities  (calculated)1,293
+/- 0
Total Stockholder Equity
Common Stock87,454
Retained Earnings -78,362
Other Stockholders Equity 3,263
Total Stockholder Equity (as reported)12,355
Total Stockholder Equity (calculated)12,355
+/-0
Other
Capital Stock87,454
Cash and Short Term Investments 10,103
Common Stock Shares Outstanding 1,976,306
Liabilities and Stockholders Equity 15,264
Net Debt -9,070
Net Invested Capital 12,355
Net Tangible Assets 12,355
Net Working Capital 9,211
Short Long Term Debt Total 1,033



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-30
> Total Assets 
7,865
7,933
11,527
7,971
5,037
3,435
732
1,909
1,959
3,472
1,332
1,723
7,285
5,211
3,275
7,667
6,043
52,599
45,814
4,470
4,768
3,909
23,675
15,264
15,26423,6753,9094,7684,47045,81452,5996,0437,6673,2755,2117,2851,7231,3323,4721,9591,9097323,4355,0377,97111,5277,9337,865
   > Total Current Assets 
6,313
5,868
6,470
5,172
3,317
2,567
542
1,428
1,483
3,260
1,031
1,481
7,003
4,929
3,024
7,314
5,503
16,365
45,433
4,191
4,456
3,378
21,789
10,826
10,82621,7893,3784,4564,19145,43316,3655,5037,3143,0244,9297,0031,4811,0313,2601,4831,4285422,5673,3175,1726,4705,8686,313
       Cash And Cash Equivalents 
6,310
5,601
5,568
3,764
1,247
422
297
1,294
1,281
3,121
953
1,426
6,864
4,883
2,621
7,071
5,207
3,765
1,062
3,329
4,276
3,215
21,392
10,103
10,10321,3923,2154,2763,3291,0623,7655,2077,0712,6214,8836,8641,4269533,1211,2811,2942974221,2473,7645,5685,6016,310
       Short-term Investments 
0
0
0
5
6
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
000000000010000000065000
       Net Receivables 
0
46
92
514
870
624
1
128
173
138
76
53
137
43
402
234
243
7,416
28
794
75
73
242
469
4692427375794287,416243234402431375376138173128162487051492460
       Other Current Assets 
3
44
153
117
157
78
9
6
28
1
2
2
2
3
2
10
54
108
44,343
69
105
91
155
254
254155911056944,3431085410232221286978157117153443
   > Long-term Assets 
1,553
2,064
5,058
2,799
1,720
868
190
481
476
212
302
242
282
283
251
353
540
36,234
381
279
312
531
1,886
4,438
4,4381,88653131227938136,2345403532512832822423022124764811908681,7202,7995,0582,0641,553
       Property Plant Equipment 
1,352
1,776
4,438
2,277
1,273
737
123
481
476
212
302
242
282
283
251
353
540
22,950
381
279
312
531
1,886
4,015
4,0151,88653131227938122,9505403532512832822423022124764811237371,2732,2774,4381,7761,352
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,925
0
0
0
0
0
0
0000009,92500000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
0
0
0
0
0
000008800000000000000000
       Intangible Assets 
201
288
619
522
447
131
67
0
0
0
0
0
0
0
0
0
0
3,351
13,215
0
0
0
0
0
0000013,2153,351000000000067131447522619288201
       Other Assets 
0
1,484
3,710
1,269
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
423
42300000000000000000001,2693,7101,4840
> Total Liabilities 
11
618
1,328
1,598
1,582
1,327
205
317
409
462
300
329
394
439
500
566
696
38,693
38,711
468
533
700
2,561
2,909
2,9092,56170053346838,71138,6936965665004393943293004624093172051,3271,5821,5981,32861811
   > Total Current Liabilities 
11
593
1,156
1,435
1,443
1,272
205
317
409
462
300
329
394
439
500
483
602
17,182
38,675
450
347
623
1,084
1,616
1,6161,08462334745038,67517,1826024835004393943293004624093172051,2721,4431,4351,15659311
       Short-term Debt 
0
0
0
0
91
115
37
0
0
0
0
0
0
0
0
0
0
11,242
834
0
0
135
277
258
2582771350083411,242000000000037115910000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,266
834
0
0
0
0
0
0000083411,26600000000000000000
       Accounts payable 
0
556
723
350
699
629
58
70
35
102
33
72
48
90
144
165
156
3,123
367
153
130
61
390
704
704390611301533673,123156165144904872331023570586296993507235560
       Other Current Liabilities 
0
37
433
1,084
653
528
110
246
374
360
267
257
346
349
355
318
374
2,817
38,308
297
218
427
417
655
65541742721829738,3082,8173743183553493462572673603742461105286531,084433370
   > Long-term Liabilities 
0
25
172
164
138
55
0
0
0
0
0
0
0
0
0
83
95
21,511
36
18
185
77
1,477
1,293
1,2931,47777185183621,511958300000000055138164172250
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
15,089
0
0
0
0
1,005
776
7761,005000015,08900000000000000000
       Other Liabilities 
0
0
0
7
0
32
0
0
0
0
0
0
0
0
0
83
65
10,973
36
18
185
77
472
517
51747277185183610,97365830000000003207000
> Total Stockholder Equity
7,854
7,315
10,199
6,373
3,456
2,108
527
1,592
1,550
3,010
1,033
1,394
6,891
4,773
2,776
7,101
5,347
13,906
7,103
4,002
4,235
3,209
21,114
12,355
12,35521,1143,2094,2354,0027,10313,9065,3477,1012,7764,7736,8911,3941,0333,0101,5501,5925272,1083,4566,37310,1997,3157,854
   Common Stock
7,873
7,883
12,169
17,506
17,535
19,063
19,126
16,746
16,859
21,536
21,467
24,153
31,859
32,121
31,969
38,658
40,610
55,175
60,095
59,062
62,421
64,292
86,209
87,454
87,45486,20964,29262,42159,06260,09555,17540,61038,65831,96932,12131,85924,15321,46721,53616,85916,74619,12619,06317,53517,50612,1697,8837,873
   Retained Earnings -78,362-67,645-61,429-58,356-55,847-54,302-43,824-36,231-32,012-29,522-27,348-24,968-22,759-20,504-18,526-16,809-15,154-18,599-16,955-14,080-11,133-1,970-568-19
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
71
188
358
708
1,022
747
1,129
2,720
1,322
1,476
1,413
1,404
1,512
1,808
2,039
2,713
4,891
3,195
2,795
2,331
2,363
2,550
3,263
3,2632,5502,3632,3312,7953,1954,8912,7132,0391,8081,5121,4041,4131,4761,3222,7201,1297471,022708358188710



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.